Alex Hanly – CEO – Lithium Universe (ASX:LU7) objective is to construct a Lithium Project in Québec with utmost speed, and to assist Canada facilitate the transition towards cleaner energy.
Copyright 2023 – Finance News Network
28 Feb 2024 - Chris Stevens - Chief Executive Officer & Executive Director - Coda Minerals (ASX:COD) is an advanced exploration company primed to unlock the value of the highly prospective Elizabeth Creek Copper Cobalt Project in South Australia’s world class mining jurisdiction, the Gawler Craton.
03 Nov 2023 - NOVONIX (ASX:NVX) CEO, Chris Burns, discusses securing a $100 million grant from the DOE, the company's Riverside facility expansion, graphite's future amidst China's export controls, and the pivotal role of synthetic graphite in clean energy.
23 Sep 2024 - Rob Hattersley, Group Head of Capital at MaxCap Group, provides an overview of the company, discussing the funding gap in the Australian credit market, managing risk, the tailwinds for commercial real estate debt, and opportunities within the residential and logistics property markets.
03 Aug 2020 - Kingston Resources Limited (ASX:KSN) Managing Director Andrew Corbett provides an update on the company's Misima and Livingstone Gold Projects.
17 Mar 2022 - Managing Director Kym Winter-Dewhirst talks about Venice Energy's plans to develop the world’s first LNG import facility entirely powered by renewable energy. The LNG Import and Storage terminal will be located at Outer Harbor, around 14km from Adelaide, and has been designated as “essential infrastructure” by the South Australian State Government.
05 Feb 2024 - Chariot Corporation (ASX:CC9) Managing Director Shanthar Pathmanathan and Geological Consultant Dr Edward Max Baker discuss the significance of the company's latest drill results.
03 Jun 2020 - Cyclopharm (ASX:CYC) Managing Director and CEO James McBrayer provides an update on US FDA progress with Technegas, approval in Russia and potential use of Technegas in the diagnosis and management of COVID-19.
19 Sep 2019 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director, James Graham provides an update on the company's lead product RECCE 327, including its progress with manufacturing, securing patents and presenting to a global audience.